Endpoint Ventures
ActiveVenture Capital
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Endpoint Ventures.
Key people at Endpoint Ventures.
Key people at Endpoint Ventures.
Endpoint Ventures is an investment firm registered as an SEC-registered advisor that primarily serves institutional private equity investors. While detailed public information about its mission and investment philosophy is limited, Endpoint Capital appears to focus on providing investment products and services tailored to institutional clients, likely emphasizing disciplined, data-driven approaches typical of private equity advisory firms[3].
There is some ambiguity in the search results because "Endpoint" also refers to companies in different sectors: Endpoint Health, a biotech startup focused on targeted therapies for critical illnesses, and Endpoint, a digital title and escrow company innovating in real estate transactions[1][2]. However, Endpoint Ventures as an investment firm is distinct from these portfolio companies.
Specific founding details, key partners, or the evolution of Endpoint Ventures’ focus are not publicly available in the search results. The firm's SEC registration suggests it operates with regulatory compliance typical of established investment advisors but without publicly disclosed narrative or founding history[3].
Endpoint Ventures operates within the private equity investment landscape, which is critical for providing capital and strategic guidance to growth-stage companies and mature businesses. Its role likely involves identifying promising sectors and companies, facilitating capital deployment, and influencing corporate governance to drive value creation. This function supports innovation and scaling in the broader technology and business ecosystem, although specific sectors or trends Endpoint Ventures targets are not detailed in the available information[3].
Without detailed public information, the future outlook for Endpoint Ventures can be inferred as continuing to expand its institutional client base and investment product offerings in private equity. Trends shaping its journey may include increased demand for alternative investments, growing interest in technology-driven sectors, and evolving regulatory environments. Its influence may grow as private equity continues to play a pivotal role in funding innovation and business transformation.
---
Note: The search results also mention two companies named Endpoint: Endpoint Health (a biotech company focused on critical illness therapies) and Endpoint (a digital title and escrow company in real estate). These are distinct entities and not the investment firm Endpoint Ventures[1][2].
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 1, 2022 | Curebase | $40.0M Series B | — | Addition, Ahead VC, Amplify.LA, BoxGroup, Bullpen Capital, Company Capital, Felicis Ventures, Future Planet Capital, General Atlantic, Gotham Gal Ventures, Industry Ventures, Launchpad Capital, MS&AD Ventures, Notable Capital, Plug & Play Ventures, Positive Sum VC, Resolute Ventures, TCV, Umami Capital, Xfund, Dave Pell, Greg Schroy, John M. Mueller, Mathieu Guerville, Michael Lombardi, Patrick S. Chung |
